John C. Krauss

9.3k total citations · 1 hit paper
137 papers, 3.0k citations indexed

About

John C. Krauss is a scholar working on Oncology, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, John C. Krauss has authored 137 papers receiving a total of 3.0k indexed citations (citations by other indexed papers that have themselves been cited), including 78 papers in Oncology, 30 papers in Molecular Biology and 30 papers in Pulmonary and Respiratory Medicine. Recurrent topics in John C. Krauss's work include Colorectal Cancer Treatments and Studies (30 papers), Immunotherapy and Immune Responses (23 papers) and Lung Cancer Treatments and Mutations (21 papers). John C. Krauss is often cited by papers focused on Colorectal Cancer Treatments and Studies (30 papers), Immunotherapy and Immune Responses (23 papers) and Lung Cancer Treatments and Mutations (21 papers). John C. Krauss collaborates with scholars based in United States, Germany and Japan. John C. Krauss's co-authors include H. Collmann, N. Sörensen, Robert F. Todd, Jianli Wang, Xuetao Cao, Wei Chen, S Shu, L Mayo-Bond, Liaomin Peng and Suyu Shu and has published in prestigious journals such as Science, Journal of Clinical Investigation and Nature Medicine.

In The Last Decade

John C. Krauss

132 papers receiving 3.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Sotorasib with panitumumab in chemotherapy-refractory KRASG12C-mutated colorectal cancer: a phase 1b trial

2024 49 citations Yasutoshi Kuboki, Marwan Fakih et al. Nature Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
John C. Krauss United States	31	1.3k	852	839	538	530	137	3.0k
Diane C. Arthur United States	33	858 0.6×	605 0.7×	1.0k 1.2×	1.1k 2.0×	895 1.7×	78	4.1k
J Garcı́a-Conde Spain	35	2.0k 1.5×	596 0.7×	954 1.1×	792 1.5×	1.1k 2.1×	104	3.9k
A. Keith Stewart Canada	37	1.4k 1.1×	549 0.6×	2.4k 2.8×	463 0.9×	483 0.9×	100	3.9k
Juan Luis Garcı́a Spain	29	984 0.7×	332 0.4×	1.3k 1.5×	836 1.6×	806 1.5×	127	3.2k
Scott Ely United States	28	1.6k 1.2×	674 0.8×	1.3k 1.5×	737 1.4×	1.1k 2.0×	89	3.4k
Gordana Vlahovic United States	26	2.2k 1.6×	973 1.1×	920 1.1×	1.1k 2.0×	173 0.3×	93	3.9k
José A. Martínez-Climent Spain	39	1.3k 1.0×	509 0.6×	1.9k 2.3×	865 1.6×	1.0k 2.0×	135	4.5k
Jean‐Michel Cayuela France	33	784 0.6×	552 0.6×	1.0k 1.2×	837 1.6×	487 0.9×	101	3.8k
Mark Kirschbaum United States	25	2.1k 1.5×	1.7k 2.0×	1.9k 2.2×	887 1.6×	1.1k 2.2×	66	6.2k
Christian P. Kratz Germany	37	980 0.7×	908 1.1×	2.7k 3.3×	681 1.3×	813 1.5×	151	4.9k

Countries citing papers authored by John C. Krauss

Since Specialization

Citations

This map shows the geographic impact of John C. Krauss's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John C. Krauss with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John C. Krauss more than expected).

Fields of papers citing papers by John C. Krauss

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John C. Krauss. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John C. Krauss. The network helps show where John C. Krauss may publish in the future.

Co-authorship network of co-authors of John C. Krauss

This figure shows the co-authorship network connecting the top 25 collaborators of John C. Krauss. A scholar is included among the top collaborators of John C. Krauss based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John C. Krauss. John C. Krauss is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Ciombor, Kristen K., Lianchun Xiao, Enrica Marmonti, et al.. (2026). NCI9673 (Part B): ETCTN Randomized Phase II Study of Nivolumab With or Without Ipilimumab in Refractory, Metastatic Squamous Cell Carcinoma of the Anal Canal. Journal of Clinical Oncology. 44(6). 497–507.

Hendren, Samantha, et al.. (2024). Treatment of Locally Recurrent Rectal Cancer. The Cancer Journal. 30(4). 264–271.

Kanzawa-Lee, Grace, et al.. (2024). Home-based aerobic exercise feasibility in oxaliplatin-receiving newly-diagnosed cancer survivors. European Journal of Oncology Nursing. 71. 102649–102649. 2 indexed citations

Kuboki, Yasutoshi, Marwan Fakih, John H. Strickler, et al.. (2024). Sotorasib with panitumumab in chemotherapy-refractory KRASG12C-mutated colorectal cancer: a phase 1b trial. Nature Medicine. 30(1). 265–270. 49 indexed citations breakdown →

Kanzawa-Lee, Grace, John C. Krauss, & Robert Knoerl. (2024). Exploring Chemotherapy-Induced Peripheral Neuropathy Management Practice Patterns Among Oncology Clinicians. Seminars in Oncology Nursing. 40(5). 151685–151685. 8 indexed citations

Jiang, Yun, Christopher R. Friese, Sarah T. Hawley, et al.. (2024). The Acceptance and Use of Digital Technologies for Self-Reporting Medication Safety Events After Care Transitions to Home in Patients With Cancer: Survey Study. Journal of Medical Internet Research. 26. e47685–e47685. 3 indexed citations

El‐amir, Zain, Eun-Young Choi, & John C. Krauss. (2023). Successful Treatment of Recurrent Colonic Adenocarcinoma with Metastatic Tumor Thrombus in the Superior Mesenteric Vein with Surgical Excision and Venous Reconstruction. American Journal of Case Reports. 24. e939156–e939156.

Krauss, John C., et al.. (2023). Evaluation of biliary toxicity in patients with hepatic artery infusion pumps. Journal of Oncology Pharmacy Practice. 29(8). 1915–1920. 1 indexed citations

Oberstein, Paul E., et al.. (2023). ONCX-NAV-G201: A phase 2 basket study of navicixizumab monotherapy or in combination with chemotherapy in patients with select advanced solid tumors—Colorectal Cancer Cohort (trial in progress).. Journal of Clinical Oncology. 41(4_suppl). TPS263–TPS263. 1 indexed citations

10.

Klute, Kelsey, Michael Rothe, Elizabeth Garrett‐Mayer, et al.. (2022). Cobimetinib Plus Vemurafenib in Patients With Colorectal Cancer WithBRAFMutations: Results From the Targeted Agent and Profiling Utilization Registry (TAPUR) Study. JCO Precision Oncology. 6(6). e2200191–e2200191. 16 indexed citations

11.

Sikorskii, Alla, et al.. (2020). Patient Engagement With an Automated Telephone Symptom Management Intervention: Predictors and Outcomes. Annals of Behavioral Medicine. 54(7). 484–494. 4 indexed citations

12.

Decker, Veronica, Alla Sikorskii, Charles W. Given, et al.. (2018). Effects of depressive symptomatology on cancer‐related symptoms during oral oncolytic treatment. Psycho-Oncology. 28(1). 99–106. 5 indexed citations

13.

Demetri, George D., Luis Paz‐Ares, Anna F. Farago, et al.. (2018). Efficacy and safety of entrectinib in patients with NTRK fusion-positive tumours: Pooled analysis of STARTRK-2, STARTRK-1, and ALKA-372-001. Annals of Oncology. 29. ix175–ix175. 30 indexed citations

14.

Sikorskii, Alla, et al.. (2017). Do treatment patterns alter beliefs cancer patients hold regarding oral oncolytic agents?. Psycho-Oncology. 27(3). 1005–1012. 4 indexed citations

15.

Kahl, Brad S., Fangxin Hong, Michael E. Williams, et al.. (2014). Rituximab Extended Schedule or Re-Treatment Trial for Low–Tumor Burden Follicular Lymphoma: Eastern Cooperative Oncology Group Protocol E4402. Journal of Clinical Oncology. 32(28). 3096–3102. 138 indexed citations

16.

Sahuguet, Arnaud, et al.. (2014). Open Civic Data: Of the People, For the People, By the People.. IEEE Data(base) Engineering Bulletin. 37. 15–26. 2 indexed citations

17.

Grewal, Jaspreet Singh, Naresh T. Gunaratnam, John C. Krauss, & Lauren B. Smith. (2010). Unusual case of Burkitt lymphoma with thyroid gland and abdominal involvement. American Journal of Case Reports. 11. 16–19. 1 indexed citations

18.

Peng, Liaomin, John C. Krauss, Gregory E. Plautz, et al.. (2000). T Cell-Mediated Tumor Rejection Displays Diverse Dependence Upon Perforin and IFN-γ Mechanisms That Cannot Be Predicted From In Vitro T Cell Characteristics. The Journal of Immunology. 165(12). 7116–7124. 39 indexed citations

19.

Krauss, John C. & Suyu Shu. (1997). Secretion of Biologically Active Superantigens by Mammalian Cells. Journal of Hematotherapy. 6(1). 41–51. 1 indexed citations

20.

Strome, Scott E., John C. Krauss, Alfred E. Chang, & Suyu Shu. (1993). Strategies of Lymphocyte Activation for the Adoptive Immunotherapy of Metastatic Cancer: A Review. Journal of Hematotherapy. 2(1). 63–73. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact